AMG
43
3
AIZ
78
2
T
48
3
UHS
54
-4
CTSH
65
-3
STZ
58
3
WMB
68
-2
KSS
42
-3
BK
72
-2
MA
67
-5
GS
75
-4
NTAP
61
-3
DUK
50
-2
HRL
30
-3
SYY
47
-2
FLR
48
3
LNC
45
-4
TEL
74
3
SWKS
33
-10
DVA
72
-3
AMG
43
3
AIZ
78
2
T
48
3
UHS
54
-4
CTSH
65
-3
STZ
58
3
WMB
68
-2
KSS
42
-3
BK
72
-2
MA
67
-5
GS
75
-4
NTAP
61
-3
DUK
50
-2
HRL
30
-3
SYY
47
-2
FLR
48
3
LNC
45
-4
TEL
74
3
SWKS
33
-10
DVA
72
-3
Financhill
Back

Evoke Pharma Stock Price Chart

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
13

EVOK
Evoke Pharma

Last Price:
4.56
Seasonality Move:
12.83%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVOK is experiencing slight selling pressure.

Evoke Pharma Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.42 Sell
20-day SMA: 5.6 Sell
50-day SMA: 5.06 Sell
200-day SMA: 6.08 Sell
8-day EMA: 5.26 Sell
20-day EMA: 5.44 Sell
50-day EMA: 5.33 Sell
200-day EMA: 7.36 Sell

Evoke Pharma Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 34.35 Sell
Chaikin Money Flow: -79625 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.97 - 6.05) Sell
Bollinger Bands (100): (4.55 - 6.21) Sell

Evoke Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Evoke Pharma Stock

Is Evoke Pharma Stock a Buy?

  • Evoke Pharma share price is 4.30 while EVOK 8-day simple moving average is 5.42, which is a Sell signal.
  • The stock price of EVOK is 4.30 while Evoke Pharma 20-day SMA is 5.60, which makes it a Sell.
  • Evoke Pharma 50-day simple moving average is 5.06 while EVOK share price is 4.30, making it a Sell technically.
  • EVOK stock price is 4.30 and Evoke Pharma 200-day simple moving average is 6.08, creating a Sell signal.

EVOK Technical Analysis vs Fundamental Analysis

Sell
13
Evoke Pharma (EVOK) is a Sell

Is Evoke Pharma a Buy or a Sell?

  • Evoke Pharma stock is rated a Sell
    The current Evoke Pharma [EVOK] share price is $4.30. The Score for EVOK is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.

Evoke Pharma Stock Info

Market Cap:
3.16M
Price in USD:
4.30
Share Volume:
175.17K

Evoke Pharma 52-Week Range

52-Week High:
17.88
52-Week Low:
3.54
Sell
13
Evoke Pharma (EVOK) is a Sell

Evoke Pharma Share Price Forecast

  • What is the Evoke Pharma stock price today?
    The Evoke Pharma stock price is 4.30 USD today.
  • Will EVOK stock go up or go down?
    Evoke Pharma> share price is forecast to RISE/FALL based on technical indicators
  • Is Evoke Pharma overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, Evoke Pharma is overvalued.

Is Evoke Pharma Stock a Buy?

  • Evoke Pharma share price is 4.30 while EVOK 8-day exponential moving average is 5.26, which is a Sell signal.
  • The stock price of EVOK is 4.30 while Evoke Pharma 20-day EMA is 5.44, which makes it a Sell.
  • Evoke Pharma 50-day exponential moving average is 5.33 while EVOK share price is 4.30, making it a Sell technically.
  • EVOK stock price is 4.30 and Evoke Pharma 200-day simple moving average is 7.36, creating a Sell signal.

Fundamental Analysis of Evoke Pharma

Is Evoke Pharma a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.78 per share, and an increase next year of $4.46 per share.

Technical Analysis of Evoke Pharma

Should I short Evoke Pharma stock?

* Evoke Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.